Dr Carlos Rogerio de Figueiredo and Professor Maija Hollmén at the University of Turku are exploiting uveal melanoma as a model system, to understand...
Cancer specialist Professor Fabrice André tells Innovation News Network why a new ESMO scale for DNA mutations in cancer cells should be included in...
ValiSeek Limited is a single asset company, overseeing the development of the therapeutic VAL401 through the final stages of clinical trials for the treatment...
Misvik Biology’s Dr Juha Rantala explains how a pan-cancer drug sensitivity comparison offers new insights in genomic medicine, specifically, the repurposing of targeted therapies...
How French researcher Jérôme Galon and Immuno-Oncology diagnostics company HalioDx are tackling the need for patients’ stratification for cancer treatment.
Despite considerable social awareness and...
Professor Gail ter Haar, leader of the Therapeutic Ultrasound Team at The Institute of Cancer Research, UK reflects on the impressive potential of therapeutic...
EUSA Pharma discusses its innovative approach to sourcing multi-use oncology therapeutics, enabling patients to embrace life and proving a clear competitor in the therapeutics...
BioMarker Strategies introduces SnapPath®: a fluidics-based diagnostic system that enables automated and standardised ex vivo interrogation of live solid tumour cancers.
The pharmaceutical industry is...